TULARIK

Tularik engages in the discovery and development of orally available medicines that act through the regulation of gene expression. The company is considered a pioneer in the field of cell signaling and the control of gene expression. The company is focused primarily of three main areas; inflammation, metabolic diseases and oncology. Tularik was founded by David Goeddel along with Steve McKnight and Robert Tjian in 1991. The company was acquired by Amgen for US$ 1.3 billion in 2004.
TULARIK
Industry:
Biopharma Biotechnology Genetics Health Care Pharmaceutical
Founded:
1991-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.tularik.com
Total Employee:
251+
Status:
Active
Similar Organizations
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Morria Biopharmaceuticals
Morria Biopharmaceuticals engages in the discovery and development of multi-functional anti-inflammatory drugs.
Okairos
Okairos AG is a biopharmaceutical company focused on the discovery and development of genetic T-cell vaccines, including hepatitis C virus.
Pairnomix
Pairnomix empowers physicians and patients who want to know more about rare genetic mutations and drugs that could be prescribed today.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Funding Round - Tularik
Official Site Inspections
http://www.tularik.com
- Host name: users287.vip.heteml.jp
- IP address: 157.7.189.147
- Location: Tokyo Japan
- Latitude: 35.6882
- Longitude: 139.7532
- Timezone: Asia/Tokyo
- Postal: 102-0082

More informations about "Tularik"
Tularik - Crunchbase Company Profile & Funding
Tularik engages in the discovery and development of orally available medicines that act through the regulation of gene expression. The company is considered a pioneer in the field of cell โฆSee details»
Tularik Company Profile 2024: Valuation, Investors, โฆ
Tularik General Information Description. Operator of a drug discovery and development company based in South San Francisco, California. The company specializes in research programs that include cancer, cytomegalovirus, โฆSee details»
Tularik, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Nov 1, 2024 Explore Tularik, Inc. with its drug pipeline, therapeutic area, technology platform, 7 clinical trials, 9 news, and 133 literature, Drug:T-900607, Batabulin Sodium, T-157602, โฆSee details»
Amgen Completes Acquisition of Tularik; Acquisition Enhances โฆ
"We welcome the Tularik staff into our organization and are confident that our combined research capacity will help patients by advancing important treatments for serious diseases." Pursuant โฆSee details»
Tularik - Company Profile - Tracxn
Dec 9, 2024 Tularik - Drugs for cancer, inflammation, and immune disorders. Acquired by Amgen. Raised a total funding of $60M over 2 rounds from 1 investor. Tularik has 2867 โฆSee details»
Amgen to Acquire Tularik for $1.3 Billion
Tularik's value at $25 per share based on the average Amgen stock price during a set number of trading days prior to the close of the transaction. The ... "David Goeddel has built a great โฆSee details»
Tularik Inc. | Intellectual Property & Industry Research Alliances
Tularik, Inc. engages in the discovery and development of orally available medicines that act through the regulation of gene expression. The companyโs drugs include T67, T607, T131, โฆSee details»
Tularik - Products, Competitors, Financials, Employees, โฆ
Tularik's headquarters is located at 1120 Veterans Boulevard, South San Francisco. What is Tularik's latest funding round? Tularik's latest funding round is Acq - P2P. How much did โฆSee details»
Part of Total Rewards - Amgen Inc.
โข Like Tularik, Amgen also grants stock options widely throughout the organization. After the merger date, Amgen will grant 2004 stock options under its program to all Tularik employees โฆSee details»
Tularik, Inc.:Company Profile & Technical Research,Competitor โฆ
Tularik, Inc. is headquartered in United States California. Tularik, Inc. was founded in 1991. Tularik, Inc. has a total of 522 patents . Related Topics. Regulation of gene expression โฆSee details»
Tularik - M&A Summary, Ownership, and Business Overview
Tularik currently has five drug candidates in clinical trials. In the cancer area, Tularik is currently conducting a pivotal study of T67 for the treatment of hepatocellular carcinoma and Phase 2 โฆSee details»
Tularik - Funding, Financials, Valuation & Investors - Crunchbase
Jan 1, 1991 Tularik has raised 1 round. This was a Undisclosed round raised on Jan 1, 1991. Tularik is registered under the ticker NASDAQ:TLRK . Their stock opened with $14.00 in its โฆSee details»
Tularik - LinkedIn
Tularik | 89 followers on LinkedIn. ... Novo Ventures Venture Capital and Private Equity Principals Birmingham, United Kingdom, West MidlandsSee details»
tularik.com Company Profile | Management and Employees List
Find contact information for tularik.com. Learn about their Manufacturing, Pharmaceuticals market share, competitors, and tularik.com's email format.See details»
Tularik - Contacts, Employees, Board Members, Advisors & Alumni
Tularik has 2 current employee profiles, including Co-Founder, Director of Research Steven McKnight. Tularik has 1 board member or advisor, Frederick Dotzler . ContactsSee details»
Tularik - Updates, News, Events, Signals & Triggers - Crunchbase
Tularik engages in the discovery and development of orally available medicines that act through the regulation of gene expression. Search Crunchbase. Start Free Trial . Chrome Extension. โฆSee details»
Tularik INC Reviews | Read Client Reviews of Tularik INC.
Read reviews of Tularik INC. Write and share your personal story. Your experience will help others make the right buying decision. Trustburn. Categories Log in For business. Search. โฆSee details»
Tularik - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Dec 8, 2024 Tularik is actively using 13 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Viewport Meta, and SPF. UNLOCK PREMIUM โฆSee details»
Tularik - Crunchbase
Companies like Tularik include Caladan Bio, Okairos, and Fedora Pharmaceuticals. Fedora Pharmaceuticals . Edmonton, Alberta, Canada 1-10 employees . Biopharma . Biotechnology . โฆSee details»